SCYNEXIS INC Income Taxes Disclosure
The Company’s consolidated financial statements include a tax expense of zero and $0.2 million on domestic loss before taxes of $4.7 million and $20.5 million for the years ended December 31, 2025 and 2024, respectively, and on foreign loss before taxes of $3.9 million and $0.6 million for the years ended December 31, 2025 and 2024, respectively. The income tax expense consisted of the following (dollars in thousands):
|
|
Years Ended December 31, |
|
|||||
|
|
2025 |
|
|
2024 |
|
||
Current expense: |
|
|
|
|
|
|
||
Federal |
|
$ |
— |
|
|
$ |
151 |
|
State |
|
|
— |
|
|
|
— |
|
Foreign |
|
|
— |
|
|
|
— |
|
Total current expense |
|
$ |
— |
|
|
$ |
151 |
|
The reconciliation of the U.S. statutory income tax rate to the Company's effective tax rate for income from continuing operations reflecting the requirements of ASU 2023-09, as adopted retrospectively, is as follows:
|
|
2025 |
|
|
2024 |
|
||||||||||
|
|
Amount |
|
|
Percent of Pretax Income |
|
|
Amount |
|
|
Percent of Pretax Income |
|
||||
U.S. federal statutory tax rate |
|
$ |
(1,806 |
) |
|
|
21.0 |
% |
|
$ |
(4,439 |
) |
|
|
21.0 |
% |
State and local income taxes, net of federal income tax effect (a) |
|
|
220 |
|
|
|
(2.6 |
)% |
|
|
(132 |
) |
|
|
0.6 |
% |
Foreign tax effects: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Australia |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Statutory rate difference between Australia and U.S. |
|
|
(161 |
) |
|
|
1.9 |
% |
|
|
— |
|
|
|
— |
|
Changes in valuation allowance |
|
|
1,093 |
|
|
|
(12.7 |
)% |
|
|
153 |
|
|
|
(0.7 |
)% |
Other |
|
|
(85 |
) |
|
|
1.0 |
% |
|
|
(25 |
) |
|
|
0.1 |
% |
Effects of changes in tax laws or rates enacted in current period |
|
|
— |
|
|
|
— |
|
|
|
104 |
|
|
|
(0.5 |
)% |
Tax credits: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Research and development tax credit |
|
|
(750 |
) |
|
|
8.7 |
% |
|
|
(1,235 |
) |
|
|
5.8 |
% |
Expiring credits |
|
|
— |
|
|
|
— |
|
|
|
(3,866 |
) |
|
|
18.3 |
% |
Other |
|
|
172 |
|
|
|
(2.0 |
)% |
|
|
— |
|
|
|
— |
|
Changes in valuation allowance |
|
|
1,311 |
|
|
|
(15.2 |
)% |
|
|
7,793 |
|
|
|
(36.9 |
)% |
Nontaxable or nondeductible items: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Warrant issuance |
|
|
(1,212 |
) |
|
|
14.1 |
% |
|
|
(2,942 |
) |
|
|
13.9 |
% |
Stock compensation |
|
|
280 |
|
|
|
(3.3 |
)% |
|
|
91 |
|
|
|
(0.4 |
)% |
Convertible debt interest |
|
|
102 |
|
|
|
(1.2 |
)% |
|
|
538 |
|
|
|
(2.5 |
)% |
Other |
|
|
22 |
|
|
|
(0.3 |
)% |
|
|
4 |
|
|
|
— |
|
Other adjustments |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Deferred stock-based compensation true-up |
|
|
911 |
|
|
|
(10.6 |
)% |
|
|
884 |
|
|
|
(4.2 |
)% |
Convertible debt interest |
|
|
(351 |
) |
|
|
4.1 |
% |
|
|
— |
|
|
|
— |
|
Milestone deferral true-up |
|
|
— |
|
|
|
— |
|
|
|
4,285 |
|
|
|
(20.3 |
)% |
Expiring NOLs |
|
|
— |
|
|
|
— |
|
|
|
(1,311 |
) |
|
|
6.2 |
% |
Other |
|
|
254 |
|
|
|
(3.0 |
)% |
|
|
249 |
|
|
|
(1.2 |
)% |
Effective tax rate |
|
$ |
— |
|
|
|
— |
|
|
$ |
151 |
|
|
|
(0.7 |
)% |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
(a) For the year ended December 31, 2025, state taxes in the following states listed below made up the majority (greater than 50% of the tax effect): New Jersey and Florida. |
|
|
|
|
|
|
|
|
|
|
|
|
||||
The components of deferred tax assets and liabilities as of December 31, 2025 and 2024 are as follows (in thousands):
|
|
December 31, |
|
|||||
|
|
2025 |
|
|
2024 |
|
||
Noncurrent deferred tax assets (liabilities) |
|
|
|
|
|
|
||
Accrued expenses |
|
$ |
38 |
|
|
$ |
53 |
|
Stock-based compensation |
|
|
1,376 |
|
|
|
2,238 |
|
Lease liability |
|
|
476 |
|
|
|
553 |
|
Other |
|
|
(318 |
) |
|
|
(2,300 |
) |
Capitalized Sec. 174 R&E |
|
|
12,065 |
|
|
|
13,202 |
|
Net operating loss carryforwards |
|
|
51,378 |
|
|
|
48,684 |
|
Research and development credits |
|
|
7,014 |
|
|
|
6,145 |
|
Total deferred tax assets |
|
|
72,029 |
|
|
|
68,575 |
|
Valuation allowances |
|
|
(72,029 |
) |
|
|
(68,575 |
) |
Net deferred tax assets |
|
$ |
— |
|
|
$ |
— |
|
As of December 31, 2025 and 2024, the Company had available federal net operating loss (“NOL”) carryforwards of approximately $226.4 million and $215.7 million, respectively, and state and net operating loss carryforwards of approximately $130.8 million and $122.0 million, respectively. The Company’s state and net operating loss carryforwards began to expire in 2019. As of December 31, 2025, the Company had available federal research and development credit carryforwards of $6.2 million which began to expire in 2026. For the year ended December 31, 2025, the Company did not pay income tax. For the year ended December 31, 2024, the Company paid $0.6 million for federal income tax and $0.1 million for state income tax.
We completed a Section 382 study of transactions in our stock through December 31, 2023 and concluded that we have experienced ownership changes since inception that we believe under Section 382 and 383 of the Code will result in limitations on our ability to use certain pre-ownership change NOLs and credits. In addition, we may experience subsequent ownership changes as a result of future equity offerings or other changes in the ownership of our stock, some of which are beyond our control. As a result, the amount of the NOLs and tax credit carryforwards presented in our consolidated financial statements are limited and the related amounts have been updated. Similar provisions of state tax law may also apply to limit the use of accumulated state tax attributes.
On July 4, 2025, the One Big Beautiful Bill was enacted (“OBBBA”), introducing significant and wide-ranging changes to the U.S. federal tax system. Significant components include restoration of 100% accelerated tax depreciation on qualifying property including expansion to cover qualified production property. Another major aspect includes the return to immediate expensing of domestic research and experimental expenditures (“R&E”) which in some cases may include retroactive application back to 2021 for businesses with gross receipts of less than $31.0 million or accelerated tax deductions of R&E that was previously capitalized for larger businesses. The legislation also reinstates EBITDA-based interest deductions for tax purposes and makes several business tax incentives permanent. Less favorable business provisions include limitations on tax deductions for charitable contributions.
The OBBBA modified the U.S. International Tax provisions for Global Intangible Low-Taxed Income (“GILTI”), Foreign-Derived Intangible Income (“FDII”), and the Base-erosion Anti-abuse Tax (“BEAT”) effective for tax years starting after December 31, 2025. The tax rate on GILTI, now renamed to Net CFC Tested Income (“NCTI”), is now 12.6%. The FDII rules, now renamed to Foreign Derived Deduction Eligible Income (“FDDEI”), now carry a 14% tax rate on FDDEI eligible income. The OBBB Act increases the BEAT rate from 10% to 10.5%.
On December 22, 2017, the “Tax Cuts and Jobs Act” was signed into law. The tax reform has the following effects on the Company: (1) permanently reduces the maximum corporate income tax rate from 35% to 21% effective for tax years beginning after December 31, 2017, (2) allows temporary 100% expensing for certain business assets and property placed in service after September 27, 2018 and before January 1, 2023, (3) disallows NOL carrybacks but allows for the indefinite carryforward of those NOLs which applies to losses arising in tax years beginning after December 31, 2018 and, (4) limits NOL deductions for each year equal to the lesser of the available carryover or 80% of a taxpayer’s pre-NOL deduction taxable income. This applies to losses arising in tax years ending on or after December 31, 2017. As of December 31, 2025 and 2024, the Company has concluded that it is more likely than not that the Company will not realize the benefit of its deferred tax assets due to its history of losses since inception. Accordingly, the net deferred tax assets have been fully reserved.
All tax years remain open to examination by U.S. federal and state income tax authorities because the Company has incurred cumulative net operating losses since inception.
The Company applies ASC 740-10-25-5, Income Taxes, formerly FASB Interpretation No. 48, Accounting for Uncertainty in Income Taxes, as amended, on January 1, 2009. The difference between the tax benefit recognized in the financial statements and the tax benefit claimed in the tax return is referred to as an unrecognized tax benefit.
The following is a tabular reconciliation of the total amounts of unrecognized tax benefits as of December 31, 2025 and 2024 (in thousands):
|
|
December 31, |
|
|||||
|
|
2025 |
|
|
2024 |
|
||
Unrecognized tax benefit—January 1 |
|
$ |
358 |
|
|
$ |
361 |
|
Reductions for tax positions of prior years |
|
|
(358 |
) |
|
|
— |
|
Deferred rate change |
|
|
— |
|
|
|
(3 |
) |
Unrecognized tax benefit—December 31 |
|
$ |
— |
|
|
$ |
358 |
|
The Company has no tax positions for which it is reasonably possible that the total amount of unrecognized tax benefits will significantly increase or decrease within the coming year. The Company has zero provided for interest and penalties associated with uncertain tax positions.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Mar 4, 2026 | Showing above |
| 2024 | Mar 12, 2025 | |
| 2023 | Mar 28, 2024 | |
| 2022 | Mar 31, 2023 | |
| 2021 | Mar 29, 2022 | |
| 2020 | Mar 29, 2021 | |
About Income Taxes Disclosures
The income tax disclosure reveals how much a company actually pays in taxes versus what the statutory rate would predict. Analysts focus on the effective tax rate (ETR) reconciliation, which breaks down every item driving the gap between the 21% federal rate and the company's reported ETR — including R&D credits, foreign rate differentials, and state taxes. Deferred tax assets (DTAs) and their valuation allowances signal management's confidence in future profitability: a rising allowance suggests the company doubts it can use accumulated tax benefits. Uncertain tax benefit (UTB) reserves quantify exposure to IRS challenges on aggressive positions.
Key signals to watch: sudden ETR drops without clear operational reasons, large increases in valuation allowances, growing UTB balances, and significant unremitted foreign earnings. Post-TCJA, pay attention to GILTI and BEAT provisions that affect multinational tax structures. Compare the cash taxes paid (from the cash flow statement) against the income tax provision to gauge earnings quality.